# Equinix Inc: financial statements, quarterly

EQIX · Nasdaq · CIK 1101239 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eqix.md) · [Financials](/companies/eqix/financials.md) · [Filings](/companies/eqix/filings.md) · [Insiders](/companies/eqix/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eqix/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,110 d](/filings/0001101239-26-000032.md) | [2,127](/filings/0001628280-25-021086.md) | [2,159](/filings/0001101239-25-000029.md) | [2,201](/filings/0001101239-25-000062.md) | [2,261 d](/filings/0001101239-26-000032.md) | [2,225](/filings/0001101239-26-000091.md) | [2,256](/filings/0001101239-26-000147.md) | [2,316](/filings/0001101239-26-000180.md) | [2,420 d](/filings/0001101239-26-000032.md) | [2,444](/filings/0001101239-26-000091.md) | [2,625](/filings/0001101239-26-000147.md) | [2,571](/filings/0001101239-26-000180.md) |
| Cost of revenue | $m | [1,092 d](/filings/0001101239-26-000032.md) | [1,091](/filings/0001628280-25-021086.md) | [1,082](/filings/0001101239-25-000029.md) | [1,098](/filings/0001101239-25-000062.md) | [1,196 d](/filings/0001101239-26-000032.md) | [1,084](/filings/0001101239-26-000091.md) | [1,084](/filings/0001101239-26-000147.md) | [1,142](/filings/0001101239-26-000180.md) | [1,198 d](/filings/0001101239-26-000032.md) | [1,186](/filings/0001101239-26-000091.md) | [1,230](/filings/0001101239-26-000147.md) | [1,257](/filings/0001101239-26-000180.md) |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [346 d](/filings/0001101239-26-000032.md) | [364](/filings/0001628280-25-021086.md) | [436](/filings/0001101239-25-000029.md) | [425](/filings/0001101239-25-000062.md) | [103 d](/filings/0001101239-26-000032.md) | [458](/filings/0001101239-26-000091.md) | [494](/filings/0001101239-26-000147.md) | [474](/filings/0001101239-26-000180.md) | [422 d](/filings/0001101239-26-000032.md) | [577](/filings/0001101239-26-000091.md) | [665](/filings/0001101239-26-000147.md) | [600](/filings/0001101239-26-000180.md) |
| Interest expense | $m | [103 d](/filings/0001628280-24-005350.md) | [104](/filings/0001628280-24-021647.md) | [110](/filings/0001101239-25-000029.md) | [117](/filings/0001101239-25-000062.md) | [126 d](/filings/0001101239-26-000032.md) | [122](/filings/0001101239-26-000091.md) | [135](/filings/0001101239-26-000147.md) | [128](/filings/0001101239-26-000180.md) | [142 d](/filings/0001101239-26-000032.md) | [148](/filings/0001101239-26-000091.md) | [151](/filings/0001101239-26-000147.md) | [163](/filings/0001101239-26-000180.md) |
| Income tax | $m | [43.0 d](/filings/0001101239-26-000032.md) | [46.0](/filings/0001628280-25-021086.md) | [47.0](/filings/0001101239-25-000029.md) | [54.0](/filings/0001101239-25-000062.md) | [14.0 d](/filings/0001101239-26-000032.md) | [49.0](/filings/0001101239-26-000091.md) | [38.0](/filings/0001101239-26-000147.md) | [25.0](/filings/0001101239-26-000180.md) | [48.0 d](/filings/0001101239-26-000032.md) | [56.0](/filings/0001101239-26-000091.md) | [46.0](/filings/0001101239-26-000147.md) | [48.0](/filings/0001101239-26-000180.md) |
| Net income | $m | [227 d](/filings/0001101239-26-000032.md) | [231](/filings/0001628280-25-021086.md) | [301](/filings/0001101239-25-000029.md) | [297](/filings/0001101239-25-000062.md) | [(14.0) d](/filings/0001101239-26-000032.md) | [343](/filings/0001101239-26-000091.md) | [368](/filings/0001101239-26-000147.md) | [374](/filings/0001101239-26-000180.md) | [265 d](/filings/0001101239-26-000032.md) | [415](/filings/0001101239-26-000091.md) | [479](/filings/0001101239-26-000147.md) | [489](/filings/0001101239-26-000180.md) |
| Diluted EPS | $ per share | not reported | [2.43](/filings/0001628280-25-021086.md) | [3.16](/filings/0001101239-25-000029.md) | [3.10](/filings/0001101239-25-000062.md) | not reported | [3.50](/filings/0001101239-26-000091.md) | [3.75](/filings/0001101239-26-000147.md) | [3.81](/filings/0001101239-26-000180.md) | not reported | [4.20](/filings/0001101239-26-000091.md) | [4.83](/filings/0001101239-26-000147.md) | [4.93](/filings/0001101239-26-000180.md) |
| Basic EPS | $ per share | not reported | [2.44](/filings/0001628280-25-021086.md) | [3.17](/filings/0001101239-25-000029.md) | [3.11](/filings/0001101239-25-000062.md) | not reported | [3.52](/filings/0001101239-26-000091.md) | [3.76](/filings/0001101239-26-000147.md) | [3.82](/filings/0001101239-26-000180.md) | not reported | [4.22](/filings/0001101239-26-000091.md) | [4.86](/filings/0001101239-26-000147.md) | [4.95](/filings/0001101239-26-000180.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.1](/filings/0001101239-26-000032.md) | [1.5](/filings/0001628280-25-021086.md) | [2.0](/filings/0001101239-25-000029.md) | [2.8](/filings/0001101239-25-000062.md) | [3.1](/filings/0001101239-26-000032.md) | [3.0](/filings/0001101239-26-000091.md) | [3.7](/filings/0001101239-26-000147.md) | [2.1](/filings/0001101239-26-000180.md) | [1.7](/filings/0001101239-26-000180.md) | [1.4](/filings/0001101239-26-000091.md) | [1.0](/filings/0001101239-26-000147.md) | [2.4](/filings/0001101239-26-000180.md) |
| Current assets | $bn | [3.6](/filings/0001628280-25-005126.md) | [3.2](/filings/0001628280-24-021647.md) | [3.7](/filings/0001628280-24-035638.md) | [5.1](/filings/0001628280-24-044355.md) | [5.4](/filings/0001101239-26-000032.md) | [5.5](/filings/0001628280-25-021086.md) | [6.6](/filings/0001101239-25-000029.md) | [5.0](/filings/0001101239-25-000062.md) | [5.1](/filings/0001101239-26-000180.md) | [5.3](/filings/0001101239-26-000091.md) | [4.3](/filings/0001101239-26-000147.md) | [5.8](/filings/0001101239-26-000180.md) |
| Total assets | $bn | [32.7](/filings/0001628280-25-005126.md) | [31.9](/filings/0001628280-24-021647.md) | [32.9](/filings/0001628280-24-035638.md) | [35.4](/filings/0001628280-24-044355.md) | [35.1](/filings/0001101239-26-000032.md) | [36.1](/filings/0001628280-25-021086.md) | [38.8](/filings/0001101239-25-000029.md) | [38.1](/filings/0001101239-25-000062.md) | [40.1](/filings/0001101239-26-000180.md) | [40.9](/filings/0001101239-26-000091.md) | [41.1](/filings/0001101239-26-000147.md) | [44.4](/filings/0001101239-26-000180.md) |
| Current liabilities | $bn | [3.2](/filings/0001628280-25-005126.md) | [2.9](/filings/0001628280-24-021647.md) | [3.1](/filings/0001628280-24-035638.md) | [4.4](/filings/0001628280-24-044355.md) | [3.3](/filings/0001101239-26-000032.md) | [3.3](/filings/0001628280-25-021086.md) | [4.2](/filings/0001101239-25-000029.md) | [3.1](/filings/0001101239-25-000062.md) | [3.9](/filings/0001101239-26-000180.md) | [4.5](/filings/0001101239-26-000091.md) | [3.8](/filings/0001101239-26-000147.md) | [4.5](/filings/0001101239-26-000180.md) |
| Total liabilities | $bn | [20.1](/filings/0001628280-25-005126.md) | [19.6](/filings/0001628280-24-021647.md) | [20.6](/filings/0001628280-24-035638.md) | [21.8](/filings/0001628280-24-044355.md) | [21.5](/filings/0001101239-26-000032.md) | [22.2](/filings/0001628280-25-021086.md) | [24.7](/filings/0001101239-25-000029.md) | [23.9](/filings/0001101239-25-000062.md) | [26.0](/filings/0001101239-26-000180.md) | [26.6](/filings/0001101239-26-000091.md) | [26.7](/filings/0001101239-26-000147.md) | [29.9](/filings/0001101239-26-000180.md) |
| Long-term debt | $bn | [13.8](/filings/0001628280-24-005350.md) | [13.7](/filings/0001628280-24-021647.md) | [14.5](/filings/0001628280-24-035638.md) | [15.4](/filings/0001628280-24-044355.md) | [15.3](/filings/0001628280-25-005126.md) | [15.9](/filings/0001628280-25-021086.md) | [18.1](/filings/0001101239-25-000029.md) | [17.3](/filings/0001101239-25-000062.md) | not reported | [19.8](/filings/0001101239-26-000091.md) | [19.9](/filings/0001101239-26-000147.md) | [22.8](/filings/0001101239-26-000180.md) |
| Current portion of debt | $bn | [1.0](/filings/0001628280-25-005126.md) | not reported | not reported | not reported | [1.2](/filings/0001101239-26-000032.md) | not reported | not reported | not reported | [1.3](/filings/0001101239-26-000032.md) | not reported | not reported | not reported |
| Shareholders' equity | $bn | [12.5](/filings/0001628280-25-005126.md) | [12.3](/filings/0001628280-24-035638.md) | [12.3](/filings/0001628280-24-035638.md) | [13.6](/filings/0001628280-24-044355.md) | [13.5](/filings/0001101239-26-000032.md) | [13.9](/filings/0001628280-25-021086.md) | [14.1](/filings/0001101239-25-000029.md) | [14.2](/filings/0001101239-25-000062.md) | [14.2](/filings/0001101239-26-000180.md) | [14.3](/filings/0001101239-26-000091.md) | [14.4](/filings/0001101239-26-000147.md) | [14.5](/filings/0001101239-26-000180.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [999 d](/filings/0001101239-26-000032.md) | [598](/filings/0001628280-25-021086.md) | [912 d](/filings/0001101239-25-000029.md) | [758 d](/filings/0001101239-25-000062.md) | [981 d](/filings/0001101239-26-000032.md) | [809](/filings/0001101239-26-000091.md) | [944 d](/filings/0001101239-26-000147.md) | [1,014 d](/filings/0001101239-26-000180.md) | [1,144 d](/filings/0001101239-26-000032.md) | [717](/filings/0001101239-26-000091.md) | [1,067 d](/filings/0001101239-26-000147.md) | [1,243 d](/filings/0001101239-26-000180.md) |
| Capital expenditure | $m | [996 d](/filings/0001101239-26-000032.md) | [707](/filings/0001628280-25-021086.md) | [648](/filings/0001101239-25-000029.md) | [724](/filings/0001101239-25-000062.md) | [987 d](/filings/0001101239-26-000032.md) | [750](/filings/0001101239-26-000091.md) | [989](/filings/0001101239-25-000029.md) | [1,136](/filings/0001101239-25-000062.md) | [1,436 d](/filings/0001101239-26-000032.md) | [1,256](/filings/0001101239-26-000091.md) | not reported | not reported |
| Dividends paid | $m | [403 d](/filings/0001101239-26-000032.md) | [412](/filings/0001628280-25-021086.md) | [405 d](/filings/0001101239-25-000029.md) | [413 d](/filings/0001101239-25-000062.md) | [413 d](/filings/0001101239-26-000032.md) | [468](/filings/0001101239-26-000091.md) | [460 d](/filings/0001101239-26-000147.md) | [467 d](/filings/0001101239-26-000180.md) | [461 d](/filings/0001101239-26-000032.md) | [519](/filings/0001101239-26-000091.md) | [510 d](/filings/0001101239-26-000147.md) | [518 d](/filings/0001101239-26-000180.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [93.3](/filings/0001628280-24-021647.md) | [93.9](/filings/0001628280-24-035638.md) | [94.2](/filings/0001628280-24-044355.md) | [95.2](/filings/0001628280-25-021086.md) | [95.2](/filings/0001101239-25-000029.md) | [95.7](/filings/0001101239-25-000062.md) | [97.9](/filings/0001101239-26-000091.md) | [98.1](/filings/0001101239-26-000147.md) | [98.2](/filings/0001101239-26-000180.md) | [98.7](/filings/0001101239-26-000091.md) | [99.1](/filings/0001101239-26-000147.md) | [99.3](/filings/0001101239-26-000180.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 98,988,318 at 2026-10-27, from the cover of the [10-Q filed 2026-10-28](/filings/0001101239-26-000180.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 05:26 ET. No prices; not investment advice.